Illumina (Germany) Today

ILU Stock  EUR 76.65  4.65  5.72%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Illumina is trading at 76.65 as of the 27th of March 2025. This is a 5.72 percent decrease since the beginning of the trading day. The stock's lowest day price was 76.65. Illumina has about a 24 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 27th of December 2024 and ending today, the 27th of March 2025. Click here to learn more.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. The company was incorporated in 1998 and is headquartered in San Diego, California. ILLUMINA INC operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. The company has 158 M outstanding shares. More on Illumina

Moving together with Illumina Stock

  0.71TN8 Thermo Fisher ScientificPairCorr
  0.8DAP DanaherPairCorr
  0.81DAP DanaherPairCorr

Moving against Illumina Stock

  0.9DBPE Xtrackers LevDAXPairCorr
  0.78E908 Lyxor 1PairCorr
  0.58WX8 WuXi AppTecPairCorr
  0.56PKX POSCO HoldingsPairCorr
  0.449NPA NIPPON PROLOGIS REITPairCorr
  0.36JUA Japan Real Estate SplitPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Illumina Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Illumina's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Illumina or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEOThomas OLeary
Business ConcentrationDiagnostics & Research, Healthcare (View all Sectors)
Illumina (ILU) is traded on Frankfurt Exchange in Germany and employs 11,500 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 29.8 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Illumina's market, we take the total number of its shares issued and multiply it by Illumina's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Illumina classifies itself under Healthcare sector and is part of Diagnostics & Research industry. The entity has 158 M outstanding shares. Illumina has accumulated about 4.63 B in cash with 392 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 31.71.
Check Illumina Probability Of Bankruptcy
Ownership Allocation
Illumina has a total of 158 Million outstanding shares. The majority of Illumina outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Illumina to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Illumina. Please pay attention to any change in the institutional holdings of Illumina as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Institutions93.46%PublicI...100%
Check Illumina Ownership Details

Illumina Risk Profiles

Although Illumina's alpha and beta are two of the key measurements used to evaluate Illumina's performance over the market, the standard measures of volatility play an important role as well.

Illumina Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Illumina without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Center Now

   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Module

Illumina Corporate Management

Elected by the shareholders, the Illumina's board of directors comprises two types of representatives: Illumina inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Illumina. The board's role is to monitor Illumina's management team and ensure that shareholders' interests are well served. Illumina's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Illumina's outside directors are responsible for providing unbiased perspectives on the board's policies.
Julian AndrewsHead of Strategy and Planning and Head of Business Development and Group RehabilitationProfile
Francis deSouzaCEO DirectorProfile
Lynne SaintNon-Executive Independent DirectorProfile
Charles DadswellGen VPProfile
Adele StrattonGeneral Manager - Finance, Investor Relations and Corporate AffairsProfile

Additional Information and Resources on Investing in Illumina Stock

When determining whether Illumina offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Illumina's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Illumina Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Illumina Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Illumina. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Illumina Stock please use our How to Invest in Illumina guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.